AI summary

75% confidence

This study analyzes the burden of chronic respiratory diseases in Asia from 1990 to 2023 using data from the Global Burden of Disease Study 2023. It aims to characterize variations in disease patterns across different Asian countries and regions while identifying key risk factors. The research highlights the necessity for targeted interventions given that over half of the world's population resides in Asia.

Generated by MESSAI extraction pipeline · review against source PDF

Extraction

Reported parameters

No values extracted from this paper yet.

No 3D model is mapped to this paper yet. Parameter ranges above still place reported values on the literature distribution.

Abstract

Chronic respiratory diseases are an important global issue, particularly in Asia, where burden patterns vary widely across countries. With more than half the world's population living in Asia, understanding the national and regional burden of chronic respiratory diseases is essential; however, research on this area remains inadequate. We aimed to investigate the burden of chronic respiratory diseases in Asia at national and regional levels, and to identify key risk factors.

Key findings

  • Chronic respiratory diseases represent a significant and growing health burden across diverse Asian nations.
  • Burden patterns exhibit substantial heterogeneity between countries and regions within Asia.
  • Specific risk factors driving this burden vary significantly by location, requiring tailored public health strategies.

Identifiers

PubMed
41579872
Journal
The Lancet. Respiratory medicine
Year
2026